JUBLPHARMA.BO Financials

Financials

Trends

* Timeframes marked with (Est.) are analyst estimates based on consensus data.

Details

Breakdown	2026	2025	Change %
Total Revenue	82.251.000.000	71.921.000.000	14.4%
Cost of Revenue	29.911.000.000	26.116.000.000	14.5%
Gross Profit	52.340.000.000	45.805.000.000	14.3%
	44.146.000.000	37.737.000.000	17.0%
Operating Income	8.194.000.000	8.068.000.000	1.6%
Pretax Income	6.141.000.000	9.806.000.000	37.4%
Net Income Common Stockholders	3.985.000.000	8.394.000.000	52.5%
	--	--	--
	--	--	--